Acesion Pharma Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
2ndary - Private
- Investors
-
7
Acesion Pharma General Information
Description
Developer of a biotech company intended to advance medical drugs for the treatment of atrial fibrillation. The company inhibits a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm and maintenance of sinus rhythm, enabling healthcare professionals with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.
Contact Information
Website
www.acesionpharma.comCorporate Office
- Nordre Fasanvej 215
- 2000 Frederiksberg
- Denmark
Corporate Office
- Nordre Fasanvej 215
- 2000 Frederiksberg
- Denmark
Acesion Pharma Timeline
Acesion Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | 01-Feb-2026 | Completed | Clinical Trials - Phase 2 | |||
| 9. Later Stage VC (Series B) | 26-Sep-2023 | Completed | Clinical Trials - Phase 2 | |||
| 8. Later Stage VC | 03-May-2019 | Completed | Clinical Trials - Phase 2 | |||
| 7. Grant | 12-Mar-2019 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC | 03-Nov-2016 | Completed | Clinical Trials - Phase 2 | |||
| 5. Early Stage VC | 17-Dec-2014 | Completed | Startup | |||
| 4. Grant | 16-Dec-2013 | Completed | Startup | |||
| 3. Grant | 01-Dec-2013 | Completed | Startup | |||
| 2. Early Stage VC | 05-May-2013 | $1.27M | $1.27M | Completed | Startup | |
| 1. Seed Round | 01-Dec-2011 | Completed | Startup |
Acesion Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 8,413,590 | $0.4 | $0.4 | 1x | $0.4 | 7.3% | ||
| Ordinary | 1,407,140 | $0.04 | $0.04 | 1x | $0.04 | 1.22% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Acesion Pharma Comparisons
Industry
Financing
Details
Acesion Pharma Competitors (3)
One of Acesion Pharma’s 3 competitors is Azure Biotech, a Venture Capital-Backed company based in North Brunswick, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Azure Biotech | Venture Capital-Backed | North Brunswick, NJ | ||||
| Mercator MedSystems | Venture Capital-Backed | San Leandro, CA | ||||
| Elixir Medical | Venture Capital-Backed | Milpitas, CA |
Acesion Pharma Patents
Acesion Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4805343-A1 | Highly soluble salts | Pending | 09-Nov-2023 | ||
| WO-2025099044-A1 | Highly soluble salts | Inactive | 09-Nov-2023 | ||
| EP-4245753-A1 | Imidazole derivatives as potassium channel inhibitors | Inactive | 17-Mar-2022 | ||
| EP-4493546-A1 | Imidazole derivatives as potassium channel inhibitors | Active | 17-Mar-2022 | ||
| EP-4493546-B1 | Imidazole derivatives as potassium channel inhibitors | Active | 17-Mar-2022 | C07D233/88 |
Acesion Pharma Signals
Acesion Pharma Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alpha Wave Global | Growth/Expansion | Minority | ||
| Canaan Partners | Venture Capital | Minority | ||
| Global BioAccess Fund | Venture Capital | Minority | ||
| KB Investment | Venture Capital | Minority | ||
| Fontus Capital | Venture Capital | Minority |
Acesion Pharma FAQs
-
When was Acesion Pharma founded?
Acesion Pharma was founded in 2011.
-
Where is Acesion Pharma headquartered?
Acesion Pharma is headquartered in Frederiksberg, Denmark.
-
What is the size of Acesion Pharma?
Acesion Pharma has 22 total employees.
-
What industry is Acesion Pharma in?
Acesion Pharma’s primary industry is Drug Discovery.
-
Is Acesion Pharma a private or public company?
Acesion Pharma is a Private company.
-
What is Acesion Pharma’s current revenue?
The current revenue for Acesion Pharma is .
-
How much funding has Acesion Pharma raised over time?
Acesion Pharma has raised $71.6M.
-
Who are Acesion Pharma’s investors?
Alpha Wave Global, Canaan Partners, Global BioAccess Fund, KB Investment, and Fontus Capital are 5 of 7 investors who have invested in Acesion Pharma.
-
Who are Acesion Pharma’s competitors?
Azure Biotech, Mercator MedSystems, and Elixir Medical are competitors of Acesion Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process